5-amino-1MQ
Early research5-amino-1MQ means 5-amino-1-methylquinolinium, a small-molecule NNMT enzyme inhibitor.
Research, risks & sources
Early research- What the name means
- 5-amino-1MQ means 5-amino-1-methylquinolinium, a small-molecule NNMT enzyme inhibitor.
- Research & intended effects
- Investigated for obesity and metabolic function through inhibition of NNMT, an enzyme involved in cellular metabolism. Mouse studies examine how this approach changes weight-related and metabolic outcomes.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
ACE-031
Human researchACE-031 is an experimental activin receptor fusion protein that inhibits myostatin-related signaling.
Research, risks & sources
Human research- What the name means
- ACE-031 is an experimental activin receptor fusion protein that inhibits myostatin-related signaling.
- Research & intended effects
- Studied for muscle outcomes in boys with Duchenne muscular dystrophy.
- Possible side effects
- A trial stopped early over nosebleeds and widened small blood vessels (telangiectasias).
- Interactions
- Drug-interaction data are limited.
Adamax
Limited documentationAdamax is an ACTH/Semax-related designer peptide name.
Research, risks & sources
Limited documentation- What the name means
- Adamax is an ACTH/Semax-related designer peptide name.
- Research & intended effects
- Promoted as a cognitive-enhancement candidate. The intended direction is attention and cognition; Medsafe identifies Adamax in this proposed-use category. Published recovery research on Semax provides context, not an Adamax efficacy result.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Adipotide
Early researchAdipotide is an experimental peptidomimetic targeting blood vessels in fat tissue.
Research, risks & sources
Early research- What the name means
- Adipotide is an experimental peptidomimetic targeting blood vessels in fat tissue.
- Research & intended effects
- Designed to target the blood supply of fat tissue. A monkey study explored weight reduction and insulin-resistance outcomes, testing a different obesity strategy from appetite suppression.
- Possible side effects
- Kidney-related toxicity was observed in animal research; human safety is not adequately characterized here.
- Interactions
- Drug-interaction data are limited.
AHK-Cu
Early researchAHK-Cu is the copper complex of alanyl-histidyl-lysine.
Research, risks & sources
Early research- What the name means
- AHK-Cu is the copper complex of alanyl-histidyl-lysine.
- Research & intended effects
- Investigated for hair growth. Experiments using isolated human hair follicles and cultured cells examine whether this copper peptide influences follicle growth and supporting cells.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
AICAR
Early researchAICAR commonly refers to aminoimidazole carboxamide riboside, an experimental AMPK-activating compound.
Research, risks & sources
Early research- What the name means
- AICAR commonly refers to aminoimidazole carboxamide riboside, an experimental AMPK-activating compound.
- Research & intended effects
- Investigated for metabolic adaptations associated with exercise. Mouse experiments explore AMPK activation, a cellular energy-sensing pathway, and its relationship to endurance physiology.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Alprostadil
Clinical referenceAlprostadil is prostaglandin E1, a signaling molecule that relaxes smooth muscle.
Research, risks & sources
Clinical reference- What the name means
- Alprostadil is prostaglandin E1, a signaling molecule that relaxes smooth muscle.
- Research & intended effects
- A specific formulation is used for erectile dysfunction; other formulations have different indications.
- Possible side effects
- Pain, low blood pressure and prolonged erection or priapism are important risks.
- Interactions
- Anticoagulants increase bleeding risk. Safety with other injected erectile-dysfunction medicines is not established.
AOD-9604
Early researchAOD-9604 is an experimental modified fragment related to human growth hormone.
Research, risks & sources
Early research- What the name means
- AOD-9604 is an experimental modified fragment related to human growth hormone.
- Research & intended effects
- Developed to investigate whether a small growth-hormone-related fragment can influence fat metabolism separately from the effects of the full hormone. Animal work explores fat breakdown and body-weight regulation.
- Possible side effects
- Limited safety data; immune-reaction concerns and serious reports with uncertain causation.
- Interactions
- Drug-interaction data are limited.
ARA-290
Human researchARA-290 is an erythropoietin-derived experimental peptide, also called cibinetide.
Research, risks & sources
Human research- What the name means
- ARA-290 is an erythropoietin-derived experimental peptide, also called cibinetide.
- Research & intended effects
- Small human trials investigated symptoms of small-fiber neuropathy in sarcoidosis.
- Possible side effects
- A small pilot trial cannot establish uncommon or long-term harms.
- Interactions
- Drug-interaction data are limited.
Botulinum toxin (product unspecified)
Clinical referenceBotulinum toxins block nerve signaling to muscles; different medicinal formulations are not interchangeable.
Research, risks & sources
Clinical reference- What the name means
- Botulinum toxins block nerve signaling to muscles; different medicinal formulations are not interchangeable.
- Research & intended effects
- Specific products are used for conditions such as spasticity and chronic migraine, and for cosmetic indications.
- Possible side effects
- Weakness and toxin spread can cause life-threatening swallowing or breathing problems.
- Interactions
- Aminoglycoside antibiotics and other medicines that affect neuromuscular transmission may intensify effects.
BPC + TB blend
CombinationA combination identified as BPC + TB blend. Each component is a distinct substance.
Research, risks & sources
Combination- What the name means
- A combination identified as BPC + TB blend. Each component is a distinct substance.
- Research & intended effects
- A tissue-repair concept pairing BPC-157’s tendon-healing research with thymosin-related cell-migration research. The intended goal is recovery after injury; the sources describe the components separately.
- Possible side effects
- The combined side-effect profile is not established here; component risks may overlap.
- Interactions
- Drug-interaction data are limited.
BPC-157
Early researchBPC-157 is a synthetic gastric pentadecapeptide; BPC is commonly expanded as body protection compound.
Research, risks & sources
Early research- What the name means
- BPC-157 is a synthetic gastric pentadecapeptide; BPC is commonly expanded as body protection compound.
- Research & intended effects
- Investigated for tendon and soft-tissue repair. Rat injury studies examine how it affects healing tissue, making recovery after injury the central research question.
- Possible side effects
- Human safety data are limited; immune reactions are a concern.
- Interactions
- Drug-interaction data are limited.
BPC-157 + GHK-Cu + TB500
CombinationA combination identified as BPC-157 + GHK-Cu + TB500. Each component is a distinct substance.
Research, risks & sources
Combination- What the name means
- A combination identified as BPC-157 + GHK-Cu + TB500. Each component is a distinct substance.
- Research & intended effects
- A tissue-repair concept combining tendon-healing, collagen and thymosin-related research. Its rationale is to address several aspects of tissue rebuilding; the source studies concern individual ingredients.
- Possible side effects
- The combined side-effect profile is not established here; component risks may overlap.
- Interactions
- Drug-interaction data are limited.
BPC-157 + GHK-Cu + TB500 + KPV
CombinationA combination identified as BPC-157 + GHK-Cu + TB500 + KPV. Each component is a distinct substance.
Research, risks & sources
Combination- What the name means
- A combination identified as BPC-157 + GHK-Cu + TB500 + KPV. Each component is a distinct substance.
- Research & intended effects
- Combines tissue-repair and collagen research with KPV’s intestinal-inflammation research. The intended concept is repair plus inflammatory control; evidence linked here comes from the separate components.
- Possible side effects
- The combined side-effect profile is not established here; component risks may overlap.
- Interactions
- Drug-interaction data are limited.
Bremelanotide (PT-141)
Clinical referencePT-141 is bremelanotide, a melanocortin receptor agonist.
Research, risks & sources
Clinical reference- What the name means
- PT-141 is bremelanotide, a melanocortin receptor agonist.
- Research & intended effects
- A specific medicine is used for acquired, generalized hypoactive sexual desire disorder in eligible premenopausal women.
- Possible side effects
- Nausea, flushing, headache, darker skin patches and transient blood-pressure increases. Contraindicated with uncontrolled hypertension or known cardiovascular disease.
- Interactions
- Can reduce oral naltrexone exposure and delay absorption of oral medicines.
Bronchogen
Early researchBronchogen is an experimental synthetic peptide bioregulator.
Research, risks & sources
Early research- What the name means
- Bronchogen is an experimental synthetic peptide bioregulator.
- Research & intended effects
- Investigated for tissue-growth regulation. Experiments in isolated rat tissues explore whether short peptide signals can change growth responses, a proposed route toward tissue-specific repair research.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Cagrilintide
Human researchCagrilintide is a long-acting analogue of amylin, a hormone involved in satiety.
Research, risks & sources
Human research- What the name means
- Cagrilintide is a long-acting analogue of amylin, a hormone involved in satiety.
- Research & intended effects
- Human trials investigate weight management.
- Possible side effects
- Reported effects include nausea, vomiting, diarrhea, constipation and injection-site reactions. In the REDEFINE 1 cagrilintide arm, digestive events were mainly temporary and mild to moderate.
- Interactions
- Drug-interaction data are limited.
Cagrilintide + Semaglutide
Human researchA combination of cagrilintide, an amylin analogue, and semaglutide, a GLP-1 receptor agonist.
Research, risks & sources
Human research- What the name means
- A combination of cagrilintide, an amylin analogue, and semaglutide, a GLP-1 receptor agonist.
- Research & intended effects
- Co-administration has been studied for blood sugar and weight outcomes in type 2 diabetes. This does not establish equivalence of every combination formulation.
- Possible side effects
- Nausea, vomiting, diarrhea, constipation and abdominal pain were frequent in REDEFINE 1, generally mild to moderate. Nausea, vomiting and diarrhea peaked during dose escalation and declined afterward; constipation could persist. Gallbladder and other digestive disorders were among serious events reported in the combination group.
- Interactions
- The semaglutide component makes insulin or sulfonylurea-related hypoglycemia and delayed absorption of oral medicines relevant concerns. Trial findings for this two-drug combination do not establish the safety of adding further weight-management compounds.
Cardiogen
Early researchCardiogen is an experimental synthetic peptide bioregulator.
Research, risks & sources
Early research- What the name means
- Cardiogen is an experimental synthetic peptide bioregulator.
- Research & intended effects
- Investigated for tissue-growth regulation. Experiments in isolated rat tissues explore whether short peptide signals can change growth responses, a proposed route toward tissue-specific repair research.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Cartalax
Limited documentationCartalax is a short-peptide bioregulator name associated with connective-tissue research.
Research, risks & sources
Limited documentation- What the name means
- Cartalax is a short-peptide bioregulator name associated with connective-tissue research.
- Research & intended effects
- The proposed application is cartilage maintenance and repair. The broader research question is whether short peptides can steer cells toward cartilage-building activity; work in this field examines chondrocyte differentiation and matrix proteins. The linked research overview provides field context, not a Cartalax clinical result.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Cerebrolysin
Human researchCerebrolysin is a peptide preparation investigated for neurological recovery, not one isolated compound.
Research, risks & sources
Human research- What the name means
- Cerebrolysin is a peptide preparation investigated for neurological recovery, not one isolated compound.
- Research & intended effects
- Human trials investigate neurological recovery after stroke. Researchers assess whether this peptide preparation can support recovery of function following brain injury.
- Possible side effects
- The cited trial does not establish a complete adverse-effect profile for other populations or uses.
- Interactions
- Drug-interaction data are limited.
Chonluten
Early researchChonluten is an experimental three-amino-acid peptide bioregulator.
Research, risks & sources
Early research- What the name means
- Chonluten is an experimental three-amino-acid peptide bioregulator.
- Research & intended effects
- Investigated for control of inflammation. Experiments in monocytes, a type of immune cell, examine signaling changes that could inform future work on inflammatory conditions.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
CJC without DAC + Ipamorelin
CombinationA combination identified as CJC without DAC + Ipamorelin. Each component is a distinct substance.
Research, risks & sources
Combination- What the name means
- A combination identified as CJC without DAC + Ipamorelin. Each component is a distinct substance.
- Research & intended effects
- Pairs GHRH-related signaling with ipamorelin’s ghrelin-receptor pathway. The rationale is to influence growth-hormone release through two signals; the linked studies describe the separate pathways, not a demonstrated benefit of this blend.
- Possible side effects
- The combined side-effect profile is not established here; component risks may overlap.
- Interactions
- Drug-interaction data are limited.
CJC-1295 with DAC
Human researchCJC-1295 with DAC is a long-acting growth hormone-releasing hormone analogue; DAC refers to a drug affinity complex.
Research, risks & sources
Human research- What the name means
- CJC-1295 with DAC is a long-acting growth hormone-releasing hormone analogue; DAC refers to a drug affinity complex.
- Research & intended effects
- Investigated for sustained stimulation of growth hormone and IGF-1. Human research measures how the long-acting design changes these hormone levels over time.
- Possible side effects
- Increased heart rate and systemic vasodilation have been reported.
- Interactions
- Drug-interaction data are limited.
CJC-1295 without DAC
Limited documentationThe name specifies a CJC-related peptide without a drug affinity complex. It must not inherit the identity or findings of CJC-1295 with DAC.
Research, risks & sources
Limited documentation- What the name means
- The name specifies a CJC-related peptide without a drug affinity complex. It must not inherit the identity or findings of CJC-1295 with DAC.
- Research & intended effects
- The intended research direction is stimulation of growth-hormone release using a GHRH-related peptide without the long-acting attachment. The relevant questions are pulse duration and endocrine response; studies of CJC-1295 with DAC concern a different preparation.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Cortagen
Early researchCortagen is an experimental short peptide bioregulator.
Research, risks & sources
Early research- What the name means
- Cortagen is an experimental short peptide bioregulator.
- Research & intended effects
- Investigated for regulation of cell activity through chromatin, the material that packages DNA. Human-cell experiments explore how short peptides influence the accessibility of genetic information, a proposed starting point for tissue-maintenance research.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Crystagen
Early researchCrystagen is a short-peptide name used in experimental immune research; exact sequence is not resolved by the cited abstract.
Research, risks & sources
Early research- What the name means
- Crystagen is a short-peptide name used in experimental immune research; exact sequence is not resolved by the cited abstract.
- Research & intended effects
- Investigated for age-related changes in immune function, with experiments focused on immune activity in the spleen.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Dermorphin
Human researchDermorphin is a potent opioid-like peptide originally identified in frog skin.
Research, risks & sources
Human research- What the name means
- Dermorphin is a potent opioid-like peptide originally identified in frog skin.
- Research & intended effects
- Pain research examines the effects of this opioid-active peptide on spinal pain pathways. Early human experiments measured pain-related reflexes.
- Possible side effects
- Its opioid activity is clinically significant; the cited study does not characterize a complete safety profile.
- Interactions
- An interaction with the opioid blocker naloxone was studied; combinations with other medicines are not established as safe.
DSIP
Human researchDSIP means delta sleep-inducing peptide.
Research, risks & sources
Human research- What the name means
- DSIP means delta sleep-inducing peptide.
- Research & intended effects
- Developed around the idea of influencing sleep regulation. Small early human studies explored sleep responses, making sleep quality and sleep architecture its principal research themes.
- Possible side effects
- Drowsiness was reported; uncommon and long-term harms remain poorly characterized.
- Interactions
- Drug-interaction data are limited.
Elamipretide (SS-31)
Clinical referenceSS-31 is elamipretide, a peptide that binds cardiolipin in mitochondria.
Research, risks & sources
Clinical reference- What the name means
- SS-31 is elamipretide, a peptide that binds cardiolipin in mitochondria.
- Research & intended effects
- FORZINITY has a specific indication for improving muscle strength in eligible patients with Barth syndrome; this does not establish general anti-aging benefits.
- Possible side effects
- Injection-site reactions and potentially serious hypersensitivity.
- Interactions
- The narrow clinical evidence does not establish the safety of combinations with experimental compounds.
Epithalon (Epitalon)
Early researchEpithalon, also called Epitalon, is an experimental short peptide.
Research, risks & sources
Early research- What the name means
- Epithalon, also called Epitalon, is an experimental short peptide.
- Research & intended effects
- Aging research examines its effects on telomerase, the enzyme involved in maintaining chromosome ends. The cited cell study investigates telomerase activity and telomere length.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
EPO (product unspecified)
Clinical referenceEPO means erythropoietin, a hormone involved in red-blood-cell production. Medicines such as epoetin alfa are specific formulations.
Research, risks & sources
Clinical reference- What the name means
- EPO means erythropoietin, a hormone involved in red-blood-cell production. Medicines such as epoetin alfa are specific formulations.
- Research & intended effects
- Used for selected causes of anemia, rather than athletic enhancement.
- Possible side effects
- Important risks include blood clots, stroke, heart attack, hypertension and tumor progression or recurrence.
- Interactions
- Other medicines and underlying clotting risks require individual review; this is not a complete interaction reference.
FOXO4
Early researchFOXO4 names a transcription factor. It is not, by itself, an exact identity for FOXO4-DRI or another experimental peptide.
Research, risks & sources
Early research- What the name means
- FOXO4 names a transcription factor. It is not, by itself, an exact identity for FOXO4-DRI or another experimental peptide.
- Research & intended effects
- Related FOXO4-DRI research targets senescent cells in mice. Those findings cannot be assigned to an unspecified FOXO4 compound.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
GHK (without copper)
Early researchGHK stands for glycyl-histidyl-lysine, a three-amino-acid peptide with copper affinity.
Research, risks & sources
Early research- What the name means
- GHK stands for glycyl-histidyl-lysine, a three-amino-acid peptide with copper affinity.
- Research & intended effects
- Studied in the context of copper binding and tissue-repair biology. The linked collagen experiments concern its copper-bound form, GHK-Cu, which is a distinct research preparation.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
GHK-Cu
Early researchGHK-Cu is the copper complex of glycyl-histidyl-lysine.
Research, risks & sources
Early research- What the name means
- GHK-Cu is the copper complex of glycyl-histidyl-lysine.
- Research & intended effects
- Investigated for collagen production and tissue repair. Skin-cell experiments explore how the copper-peptide complex influences the proteins and cell activity involved in rebuilding tissue.
- Possible side effects
- Injectable safety remains poorly characterized; immune reactions are a concern.
- Interactions
- Drug-interaction data are limited.
GHRP-2 acetate
Human researchGHRP-2 means growth hormone-releasing peptide-2, a ghrelin-receptor agonist.
Research, risks & sources
Human research- What the name means
- GHRP-2 means growth hormone-releasing peptide-2, a ghrelin-receptor agonist.
- Research & intended effects
- Investigated for appetite stimulation and growth-hormone release. Human physiology studies examine whether activating the ghrelin pathway changes food intake and endocrine responses.
- Possible side effects
- Appetite can increase; serious events and immune-reaction concerns have also been reported.
- Interactions
- Drug-interaction data are limited.
GHRP-6 acetate
Human researchGHRP-6 means growth hormone-releasing peptide-6.
Research, risks & sources
Human research- What the name means
- GHRP-6 means growth hormone-releasing peptide-6.
- Research & intended effects
- Investigated for growth-hormone release and its relationship to sleep physiology. Human studies examine the timing and size of endocrine responses.
- Possible side effects
- Possible cortisol and blood-glucose effects; immune-reaction concerns.
- Interactions
- Drug-interaction data are limited.
Glutathione
Human researchGlutathione is a three-amino-acid antioxidant made by the body.
Research, risks & sources
Human research- What the name means
- Glutathione is a three-amino-acid antioxidant made by the body.
- Research & intended effects
- Human supplementation studies examine oxidative-stress markers. The cited oral trial found no significant improvement in those markers.
- Possible side effects
- Safety depends on formulation and route; oral trial findings do not establish injectable safety.
- Interactions
- Drug-interaction data are limited.
Gonadorelin acetate
Human researchGonadorelin is gonadotropin-releasing hormone, a signal that stimulates pituitary reproductive hormones.
Research, risks & sources
Human research- What the name means
- Gonadorelin is gonadotropin-releasing hormone, a signal that stimulates pituitary reproductive hormones.
- Research & intended effects
- Human studies examined ovulation induction in selected patients with hypothalamic amenorrhea.
- Possible side effects
- Risks depend on the clinical setting; this small study does not establish a complete adverse-effect profile.
- Interactions
- Drug-interaction data are limited.
Hexarelin acetate
Human researchHexarelin is a synthetic growth hormone-releasing peptide.
Research, risks & sources
Human research- What the name means
- Hexarelin is a synthetic growth hormone-releasing peptide.
- Research & intended effects
- Small human studies investigate hormone secretion and sleep physiology.
- Possible side effects
- Changes in cortisol and prolactin and reduced slow-wave sleep have been observed.
- Interactions
- Drug-interaction data are limited.
HGH fragment 176-191
Limited documentationThe name identifies a proposed fragment of human growth hormone, spanning residues 176–191. It is distinct from full-length growth hormone.
Research, risks & sources
Limited documentation- What the name means
- The name identifies a proposed fragment of human growth hormone, spanning residues 176–191. It is distinct from full-length growth hormone.
- Research & intended effects
- Interest in growth-hormone fragments centers on separating metabolic effects from the full hormone’s growth-promoting actions. Much of the fat-metabolism research concerns the modified fragment AOD-9604, so that evidence is relevant background rather than a result for every 176–191 preparation.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Human chorionic gonadotropin (hCG)
Clinical referencehCG means human chorionic gonadotropin, a reproductive hormone with luteinizing-hormone-like activity.
Research, risks & sources
Clinical reference- What the name means
- hCG means human chorionic gonadotropin, a reproductive hormone with luteinizing-hormone-like activity.
- Research & intended effects
- Used for selected fertility and hormonal conditions.
- Possible side effects
- Ovarian hyperstimulation, blood clots, fluid retention and allergic reactions are possible.
- Interactions
- Other fertility hormones can intensify ovarian responses; hCG can interfere with some hormone tests.
Human menopausal gonadotropin (hMG)
Clinical referencehMG means human menopausal gonadotropin; menotropins provide follicle-stimulating and luteinizing hormone activity.
Research, risks & sources
Clinical reference- What the name means
- hMG means human menopausal gonadotropin; menotropins provide follicle-stimulating and luteinizing hormone activity.
- Research & intended effects
- Specific formulations are used for ovarian stimulation in assisted reproduction.
- Possible side effects
- Ovarian hyperstimulation, multiple pregnancy and vascular complications are important risks.
- Interactions
- The cited label reports no human drug-interaction studies; combinations require specialist monitoring.
Humanin
Early researchHumanin is a short peptide investigated for cellular protection.
Research, risks & sources
Early research- What the name means
- Humanin is a short peptide investigated for cellular protection.
- Research & intended effects
- Investigated for protecting cells from injury. Neuronal experiments explore whether humanin-related peptides can reduce cellular damage, a research direction relevant to neurodegeneration.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Hyaluronic acid (form unspecified)
Clinical referenceHyaluronic acid is a water-binding substance present in connective tissues; its formulations serve different purposes.
Research, risks & sources
Clinical reference- What the name means
- Hyaluronic acid is a water-binding substance present in connective tissues; its formulations serve different purposes.
- Research & intended effects
- Specific dermal fillers are used to restore volume or soften facial lines. Findings do not transfer to every form or route.
- Possible side effects
- Filler risks include swelling, pain and bruising; accidental blood-vessel injection can cause tissue damage, blindness or stroke.
- Interactions
- Bleeding-related medicines and concurrent procedures require review for the exact formulation.
IGF-1 LR3
Early researchIGF-1 LR3 is a modified analogue of insulin-like growth factor-1.
Research, risks & sources
Early research- What the name means
- IGF-1 LR3 is a modified analogue of insulin-like growth factor-1.
- Research & intended effects
- Animal research examines growth and metabolism; one fetal-sheep study did not improve restricted fetal growth.
- Possible side effects
- Human safety is not adequately characterized here; animal studies show changes in insulin and nutrient physiology.
- Interactions
- Drug-interaction data are limited.
Ipamorelin
Human researchIpamorelin is a ghrelin-receptor agonist and growth hormone secretagogue.
Research, risks & sources
Human research- What the name means
- Ipamorelin is a ghrelin-receptor agonist and growth hormone secretagogue.
- Research & intended effects
- A human trial investigated recovery of bowel movement after abdominal surgery.
- Possible side effects
- Serious events, including deaths, occurred in intravenous research; their occurrence does not establish causation. Safety by other routes remains uncertain.
- Interactions
- Drug-interaction data are limited.
Kisspeptin-10
Human researchKisspeptin-10 is a short form of kisspeptin, a peptide involved in reproductive hormone signaling.
Research, risks & sources
Human research- What the name means
- Kisspeptin-10 is a short form of kisspeptin, a peptide involved in reproductive hormone signaling.
- Research & intended effects
- Investigated for reproductive hormone signaling. Human experiments measure pituitary hormone responses to kisspeptin, helping researchers understand the signals that coordinate reproduction.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
KPV
Early researchKPV is lysine-proline-valine, a three-amino-acid fragment related to alpha-melanocyte-stimulating hormone.
Research, risks & sources
Early research- What the name means
- KPV is lysine-proline-valine, a three-amino-acid fragment related to alpha-melanocyte-stimulating hormone.
- Research & intended effects
- Investigated for reducing intestinal inflammation. Cell and mouse studies explore whether this short peptide can alter inflammatory responses in the gut.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Liraglutide
Clinical referenceLiraglutide is a GLP-1 receptor agonist.
Research, risks & sources
Clinical reference- What the name means
- Liraglutide is a GLP-1 receptor agonist.
- Research & intended effects
- Specific medicines are used for diabetes or long-term weight management.
- Possible side effects
- Common effects include nausea, vomiting, diarrhea, constipation, indigestion, headache, fatigue, dizziness and injection-site reactions. Increased resting heart rate can occur. Important risks include pancreatitis, gallbladder disease, dehydration-related kidney injury and serious allergy. The thyroid C-cell tumor warning is based on animal findings; the label excludes people with a personal/family history of medullary thyroid cancer or MEN2.
- Interactions
- Insulin and sulfonylureas increase hypoglycemia risk. Delayed stomach emptying may affect oral medicines and matters during anesthesia or deep sedation. The label does not recommend combining with another liraglutide product or GLP-1 agonist.
Livagen
Early researchLivagen is an experimental short peptide bioregulator.
Research, risks & sources
Early research- What the name means
- Livagen is an experimental short peptide bioregulator.
- Research & intended effects
- Investigated for regulation of cell activity through chromatin, the material that packages DNA. Human-cell experiments explore how short peptides influence the accessibility of genetic information, a proposed starting point for tissue-maintenance research.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
LL-37
Human researchLL-37 is a human cathelicidin antimicrobial peptide.
Research, risks & sources
Human research- What the name means
- LL-37 is a human cathelicidin antimicrobial peptide.
- Research & intended effects
- Investigated for wound healing as well as antimicrobial activity. A human trial tested a topical preparation for venous leg ulcers, bringing the research into a specific skin-wound setting.
- Possible side effects
- Human systemic safety is uncertain; preclinical work raises reproductive and tumor-related concerns.
- Interactions
- Drug-interaction data are limited.
Matrixyl (product unspecified)
Early researchMatrixyl refers to cosmetic peptide ingredients; the cited study used palmitoyl pentapeptide-4.
Research, risks & sources
Early research- What the name means
- Matrixyl refers to cosmetic peptide ingredients; the cited study used palmitoyl pentapeptide-4.
- Research & intended effects
- Cosmetic research focuses on skin firmness and the appearance of wrinkles. The cited palmitoyl pentapeptide-4 experiment examines collagen-related gene activity in skin fibroblasts; Matrixyl formulations contain different peptide ingredients.
- Possible side effects
- Laboratory cell findings do not establish a full human side-effect profile.
- Interactions
- Drug-interaction data are limited.
Mazdutide
Human researchMazdutide is a dual glucagon and GLP-1 receptor agonist.
Research, risks & sources
Human research- What the name means
- Mazdutide is a dual glucagon and GLP-1 receptor agonist.
- Research & intended effects
- Human trials investigate weight reduction and metabolic outcomes.
- Possible side effects
- Nausea, diarrhea, vomiting and reduced appetite were reported in human trials. Early escalation research found digestive symptoms often declined over time. Low-blood-sugar events were reported in a type 2 diabetes trial in both treatment and placebo groups; those rates should not be generalized to people without diabetes.
- Interactions
- Drug-interaction data are limited.
Melanotan II (MT-2)
Human researchMT-2 means melanotan II, a cyclic melanocortin peptide.
Research, risks & sources
Human research- What the name means
- MT-2 means melanotan II, a cyclic melanocortin peptide.
- Research & intended effects
- Investigated for pigmentation and other melanocortin-related physiological responses. A small human pilot examined tanning and accompanying effects.
- Possible side effects
- Nausea, fatigue and drowsiness were reported; the small trial cannot characterize long-term harms.
- Interactions
- Drug-interaction data are limited.
Melatonin
Clinical referenceMelatonin is a hormone involved in the sleep-wake cycle.
Research, risks & sources
Clinical reference- What the name means
- Melatonin is a hormone involved in the sleep-wake cycle.
- Research & intended effects
- Studied for jet lag and some sleep-timing disorders; evidence varies by condition.
- Possible side effects
- Headache, dizziness, nausea and drowsiness; long-term safety information is limited.
- Interactions
- People using blood thinners or with epilepsy need medical supervision; other medicine interactions are possible.
MGF
Limited documentationMGF commonly denotes mechano growth factor; the name alone does not resolve which peptide or fragment is intended.
Research, risks & sources
Limited documentation- What the name means
- MGF commonly denotes mechano growth factor; the name alone does not resolve which peptide or fragment is intended.
- Research & intended effects
- Investigated for muscle repair after mechanical stress. A study of human muscle cells reported changes in progenitor-cell activity, while another study found no comparable growth effect in its muscle-cell models. This makes reproducibility and peptide identity central research questions.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
MOTS-c
Early researchMOTS-c is a mitochondrial-derived peptide encoded within the mitochondrial 12S ribosomal RNA region.
Research, risks & sources
Early research- What the name means
- MOTS-c is a mitochondrial-derived peptide encoded within the mitochondrial 12S ribosomal RNA region.
- Research & intended effects
- Investigated for insulin sensitivity and energy metabolism. Cell and animal experiments explore how a mitochondrial-derived signal influences the way cells use nutrients.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
MT-1
Human researchMT-1 refers to melanotan I, an analogue of alpha-melanocyte-stimulating hormone.
Research, risks & sources
Human research- What the name means
- MT-1 refers to melanotan I, an analogue of alpha-melanocyte-stimulating hormone.
- Research & intended effects
- Investigated for increasing skin pigmentation through melanocortin signaling. Early human work measured tanning responses, with interest in how melanin production can influence protection from light.
- Possible side effects
- The cited small studies do not establish a comprehensive or long-term safety profile.
- Interactions
- Drug-interaction data are limited.
N-acetyl Epitalon amidate
Limited documentationAn acetylated, amidated derivative of Epitalon (Epithalon).
Research, risks & sources
Limited documentation- What the name means
- An acetylated, amidated derivative of Epitalon (Epithalon).
- Research & intended effects
- Proposed within telomere and cellular-aging research. Parent Epitalon has been studied for telomerase activity in cells; the modified derivative needs its own characterization rather than inheriting those results.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
N-acetyl Selank amidate
Limited documentationA chemically modified Selank derivative with capped peptide ends.
Research, risks & sources
Limited documentation- What the name means
- A chemically modified Selank derivative with capped peptide ends.
- Research & intended effects
- Proposed for the same anxiety- and stress-related research themes as Selank. The modification raises questions about stability and activity; the linked mechanistic findings concern parent Selank.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
N-acetyl Semax amidate
Limited documentationA Semax derivative with acetyl and amide modifications at its ends.
Research, risks & sources
Limited documentation- What the name means
- A Semax derivative with acetyl and amide modifications at its ends.
- Research & intended effects
- The development idea is to modify a neurological peptide while retaining interest in recovery and cognition. Published stroke research concerns parent Semax; whether the modified form changes stability or neurological effects is a separate question.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
NAD+
Human researchNAD+ means nicotinamide adenine dinucleotide, a coenzyme involved in cellular energy reactions.
Research, risks & sources
Human research- What the name means
- NAD+ means nicotinamide adenine dinucleotide, a coenzyme involved in cellular energy reactions.
- Research & intended effects
- Researchers are exploring NAD+ metabolism because this coenzyme participates in cellular energy production. A small infusion study tracked NAD+ and its metabolites in people; the direct finding concerns how the body processes it, while healthy-aging applications remain a broader research goal.
- Possible side effects
- Small pilot studies cannot establish uncommon or long-term harms.
- Interactions
- Drug-interaction data are limited.
Ovagen
Limited documentationOvagen refers here to the short peptide Glu-Asp-Leu, not the similarly named veterinary fertility preparation.
Research, risks & sources
Limited documentation- What the name means
- Ovagen refers here to the short peptide Glu-Asp-Leu, not the similarly named veterinary fertility preparation.
- Research & intended effects
- Proposed for liver and gastrointestinal research. A 2025 computational study examined how molecular carriers bind and transport Ovagen, addressing the practical problem of peptide delivery; it did not test liver recovery in patients.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Oxytocin acetate
Clinical referenceOxytocin is a hormone involved in uterine contraction and milk release.
Research, risks & sources
Clinical reference- What the name means
- Oxytocin is a hormone involved in uterine contraction and milk release.
- Research & intended effects
- Specific medicines are used for obstetric care, including labor and postpartum bleeding.
- Possible side effects
- Excessive uterine contractions, fetal distress and water intoxication can be serious.
- Interactions
- Vasoconstrictors and some anesthetics can alter cardiovascular effects.
P21 with adamantane
Limited documentationThe name specifies an adamantane-modified P21-related compound; no exact sequence is established here.
Research, risks & sources
Limited documentation- What the name means
- The name specifies an adamantane-modified P21-related compound; no exact sequence is established here.
- Research & intended effects
- The related adamantane-containing P021 research program aims to support neuronal connections and memory. Mouse experiments investigate neurogenesis and synaptic preservation in Alzheimer-like disease models. Matching the exact sequence is necessary to connect a P21-named material to that program.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
P21 without adamantane
Limited documentationP21 is an ambiguous research name; no exact molecular sequence is established here.
Research, risks & sources
Limited documentation- What the name means
- P21 is an ambiguous research name; no exact molecular sequence is established here.
- Research & intended effects
- This name is associated with interest in neurotrophic peptides for memory and neuronal resilience. The related published P021 program examines BDNF signaling, synapses and cognition in mice; P21 without the adamantane modification should not be treated as the same molecule.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Pancragen
Early researchPancragen is an experimental synthetic peptide bioregulator.
Research, risks & sources
Early research- What the name means
- Pancragen is an experimental synthetic peptide bioregulator.
- Research & intended effects
- Investigated for tissue-growth regulation. Experiments in isolated rat tissues explore whether short peptide signals can change growth responses, a proposed route toward tissue-specific repair research.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
PE 22-28
Early researchPE 22-28 is a shortened spadin-related peptide investigated as a TREK-1 channel blocker.
Research, risks & sources
Early research- What the name means
- PE 22-28 is a shortened spadin-related peptide investigated as a TREK-1 channel blocker.
- Research & intended effects
- Developed as a short spadin analogue for antidepressant research. Cell and mouse experiments examine TREK-1 potassium-channel inhibition and antidepressant-like responses.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
PEG MGF
Limited documentationPEG-MGF denotes a polyethylene-glycol-modified MGF-related peptide. Exact identity needs confirmation.
Research, risks & sources
Limited documentation- What the name means
- PEG-MGF denotes a polyethylene-glycol-modified MGF-related peptide. Exact identity needs confirmation.
- Research & intended effects
- The design goal is to extend the persistence of an MGF-related peptide using a polyethylene-glycol attachment. Muscle-repair interest comes from MGF cell research; the linked findings concern the unmodified peptide rather than demonstrating an effect of PEG-MGF.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Pinealon
Early researchPinealon is an experimental short peptide.
Research, risks & sources
Early research- What the name means
- Pinealon is an experimental short peptide.
- Research & intended effects
- Investigated for cellular resilience under oxidative stress. Laboratory work examines cell survival, a starting point for studying protection against age- or injury-related damage.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
PNC-27
Early researchPNC-27 is an experimental peptide containing a p53-related segment and a cell-penetrating segment.
Research, risks & sources
Early research- What the name means
- PNC-27 is an experimental peptide containing a p53-related segment and a cell-penetrating segment.
- Research & intended effects
- Cancer research examines whether this p53-related peptide can disrupt tumor-cell membranes. The intended effect is selective cancer-cell destruction, studied here in laboratory cells.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Prostamax
Early researchProstamax is an experimental short peptide bioregulator.
Research, risks & sources
Early research- What the name means
- Prostamax is an experimental short peptide bioregulator.
- Research & intended effects
- Investigated for regulation of cell activity through chromatin, the material that packages DNA. Human-cell experiments explore how short peptides influence the accessibility of genetic information, a proposed starting point for tissue-maintenance research.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
PTD-DBM
Early researchPTD-DBM combines a protein transduction domain with a Dishevelled-binding motif.
Research, risks & sources
Early research- What the name means
- PTD-DBM combines a protein transduction domain with a Dishevelled-binding motif.
- Research & intended effects
- Investigated for wound regeneration through Wnt signaling, a pathway involved in tissue development and repair. The cited work examines the approach in cells and animals.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Retatrutide
Human researchRetatrutide activates GIP, GLP-1 and glucagon receptors.
Research, risks & sources
Human research- What the name means
- Retatrutide activates GIP, GLP-1 and glucagon receptors.
- Research & intended effects
- Developed to combine appetite, glucose-control and energy-metabolism pathways for obesity and type 2 diabetes. On July 23, 2026, Lilly reported positive Phase 3 TRIUMPH-2 and TRIUMPH-3 topline results for weight loss and glycemic outcomes. These are sponsor-reported findings; the program also studies obesity-related complications.
- Possible side effects
- Common trial reports include nausea, vomiting, diarrhea and constipation, often during dose escalation. Early human research also found slower stomach emptying. Other reported effects include increased heart rate, injection-site reactions and dysesthesia—unusual skin sensitivity, tingling or burning. In TRIUMPH-1, dysesthesia occurred in about 5–13% across treatment groups versus 0.9% with placebo. Low blood pressure was also reported; this can cause dizziness or lightheadedness.
- Interactions
- Low blood pressure was more frequent among TRIUMPH-1 participants taking blood-pressure medicines. Delayed stomach emptying raises a potential concern for oral-medicine absorption; specific interactions remain under study. The phase 2 obesity trial reported no clinically significant hypoglycemia. Insulin or sulfonylurea combinations need separate assessment; that finding does not establish their safety.
Retatrutide + Cagrilintide
CombinationA combination identified as Retatrutide + Cagrilintide. Each component is a distinct substance.
Research, risks & sources
Combination- What the name means
- A combination identified as Retatrutide + Cagrilintide. Each component is a distinct substance.
- Research & intended effects
- A proposed weight-management combination joining retatrutide’s three-receptor approach with cagrilintide’s amylin-related satiety pathway. The rationale is complementary appetite and metabolic signaling; the linked trial results concern the individual agents.
- Possible side effects
- The combined side-effect profile is not established here; component risks may overlap.
- Interactions
- Drug-interaction data are limited.
Selank
Early researchSelank is a synthetic seven-amino-acid peptide.
Research, risks & sources
Early research- What the name means
- Selank is a synthetic seven-amino-acid peptide.
- Research & intended effects
- Investigated for anxiety and stress-related signaling. Mechanistic research examines biological pathways involved in anxiety, with the intended effect of reducing anxious responses.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Semaglutide
Clinical referenceSemaglutide activates the GLP-1 receptor, a pathway involved in appetite and blood sugar.
Research, risks & sources
Clinical reference- What the name means
- Semaglutide activates the GLP-1 receptor, a pathway involved in appetite and blood sugar.
- Research & intended effects
- Used in specific medicines for weight management and diabetes; some formulations also have cardiovascular or other indications.
- Possible side effects
- Common effects with weight-management injections include nausea, vomiting, diarrhea, constipation, stomach pain, bloating or reflux, headache, fatigue and dizziness. Slower stomach emptying can contribute to digestive symptoms. Important risks include pancreatitis, gallbladder disease, dehydration-related kidney injury and serious allergy; diabetic eye disease can worsen in some patients. The label carries a thyroid C-cell tumor warning based on animal findings and excludes people with a personal/family history of medullary thyroid cancer or MEN2.
- Interactions
- Insulin and sulfonylureas increase low-blood-sugar risk. Delayed stomach emptying can affect oral medicines and matters during anesthesia or deep sedation because of aspiration risk. Combining with another semaglutide product or GLP-1 agonist is not recommended in the label.
Semax
Human researchSemax is a synthetic peptide investigated for neurological effects.
Research, risks & sources
Human research- What the name means
- Semax is a synthetic peptide investigated for neurological effects.
- Research & intended effects
- Investigated for neurological recovery, particularly after ischemic stroke. Human studies examine recovery following interrupted blood supply to the brain; cognitive enhancement is a separate proposed use.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Semax + Selank
CombinationA combination identified as Semax + Selank. Each component is a distinct substance.
Research, risks & sources
Combination- What the name means
- A combination identified as Semax + Selank. Each component is a distinct substance.
- Research & intended effects
- Pairs neurological-recovery research on Semax with anxiety-pathway research on Selank. The proposed goal is a combination of cognitive support and reduced anxious responses; these are ingredient-level research themes.
- Possible side effects
- The combined side-effect profile is not established here; component risks may overlap.
- Interactions
- Drug-interaction data are limited.
Sermorelin acetate
Human researchSermorelin corresponds to the active first portion of growth hormone-releasing hormone.
Research, risks & sources
Human research- What the name means
- Sermorelin corresponds to the active first portion of growth hormone-releasing hormone.
- Research & intended effects
- Investigated as a way to stimulate the body’s own growth-hormone release. Human research in children with slow growth examined whether activating this pathway supports growth.
- Possible side effects
- The cited small study does not establish a comprehensive side-effect profile.
- Interactions
- Drug-interaction data are limited.
SNAP-8
Human researchSNAP-8 is acetyl octapeptide-3, a cosmetic peptide designed around neurotransmitter-release signaling.
Research, risks & sources
Human research- What the name means
- SNAP-8 is acetyl octapeptide-3, a cosmetic peptide designed around neurotransmitter-release signaling.
- Research & intended effects
- Developed to soften the appearance of expression wrinkles. A 2024 study examined a dissolving microneedle patch containing SNAP-8 and other active ingredients; the findings concern the combined patch rather than SNAP-8 alone.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Somatropin (HGH 191AA)
Clinical referenceHGH means human growth hormone; somatropin is a manufactured form.
Research, risks & sources
Clinical reference- What the name means
- HGH means human growth hormone; somatropin is a manufactured form.
- Research & intended effects
- Used for growth hormone deficiency and specified growth disorders. These indications do not establish an anti-aging benefit.
- Possible side effects
- Swelling, joint discomfort, headache and reduced insulin sensitivity; active malignancy is a contraindication.
- Interactions
- Can alter requirements for diabetes medicines, glucocorticoids and thyroid replacement.
Survodutide
Human researchSurvodutide activates glucagon and GLP-1 receptors.
Research, risks & sources
Human research- What the name means
- Survodutide activates glucagon and GLP-1 receptors.
- Research & intended effects
- Human trials investigate weight management; the cited trial evaluates obesity.
- Possible side effects
- Nausea, vomiting and diarrhea are the main digestive effects reported in human trials. In a type 2 diabetes study, many treatment discontinuations occurred early during dose escalation, mainly because of nausea or vomiting. Frequency and tolerability vary with the study population and escalation schedule.
- Interactions
- Drug-interaction data are limited.
TB500 / Thymosin B4 acetate
Limited documentationTB500 is an ambiguous thymosin-related name. Full-length thymosin beta-4 and its fragments are different molecules.
Research, risks & sources
Limited documentation- What the name means
- TB500 is an ambiguous thymosin-related name. Full-length thymosin beta-4 and its fragments are different molecules.
- Research & intended effects
- Interest centers on tissue repair and cell migration, drawing on thymosin beta-4 biology. Full-length thymosin beta-4 eye drops have reached human dry-eye studies; one phase 2 trial missed its primary endpoints but found improvements on several secondary measures. TB500 names may refer to different sequences.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
TB500 fragment
Limited documentationA thymosin-related fragment name with no exact sequence established here. Full-length protein findings cannot be transferred automatically.
Research, risks & sources
Limited documentation- What the name means
- A thymosin-related fragment name with no exact sequence established here. Full-length protein findings cannot be transferred automatically.
- Research & intended effects
- Fragment research asks whether shorter portions of thymosin beta-4 can retain activity relevant to tissue repair and cell movement. The exact sequence matters: the linked human wound-healing work used full-length thymosin beta-4.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Teriparatide
Clinical referenceTeriparatide is an analogue of the active portion of parathyroid hormone.
Research, risks & sources
Clinical reference- What the name means
- Teriparatide is an analogue of the active portion of parathyroid hormone.
- Research & intended effects
- Used for osteoporosis in specified patients at high fracture risk.
- Possible side effects
- Nausea, joint pain, dizziness and increased calcium; avoid in people with increased baseline osteosarcoma risk.
- Interactions
- Increased calcium may increase digoxin toxicity risk.
Tesamorelin
Clinical referenceTesamorelin is an analogue of growth hormone-releasing hormone.
Research, risks & sources
Clinical reference- What the name means
- Tesamorelin is an analogue of growth hormone-releasing hormone.
- Research & intended effects
- Used to reduce excess abdominal fat in adults with HIV-associated lipodystrophy; not general weight-loss treatment.
- Possible side effects
- Fluid retention, joint pain, elevated glucose and increased IGF-1. Active malignancy is a contraindication.
- Interactions
- Interactions can involve CYP450-metabolized medicines and glucocorticoid replacement.
Tesamorelin + Ipamorelin
CombinationA combination identified as Tesamorelin + Ipamorelin. Each component is a distinct substance.
Research, risks & sources
Combination- What the name means
- A combination identified as Tesamorelin + Ipamorelin. Each component is a distinct substance.
- Research & intended effects
- Pairs tesamorelin’s growth-hormone-releasing signal with ipamorelin’s ghrelin pathway. Interest centers on endocrine response and body composition; tesamorelin’s clinical indication concerns a specific condition and preparation, not this blend.
- Possible side effects
- The combined side-effect profile is not established here; component risks may overlap.
- Interactions
- Drug-interaction data are limited.
Testagen
Early researchTestagen is a name for the four-amino-acid peptide lysine-glutamate-aspartate-glycine (KEDG).
Research, risks & sources
Early research- What the name means
- Testagen is a name for the four-amino-acid peptide lysine-glutamate-aspartate-glycine (KEDG).
- Research & intended effects
- Investigated for pituitary–thyroid signaling. A chicken study reported changes in thyroid hormone levels and recovery of thyroid structure after pituitary removal; this is an endocrine research lead, not a testosterone trial.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Thymalin
Human researchThymalin is a thymus-derived peptide preparation, rather than one fully specified peptide.
Research, risks & sources
Human research- What the name means
- Thymalin is a thymus-derived peptide preparation, rather than one fully specified peptide.
- Research & intended effects
- Early human research examined immune responses in lung disease; findings are formulation-specific.
- Possible side effects
- The cited study does not establish a complete side-effect profile.
- Interactions
- Drug-interaction data are limited.
Thymosin alpha-1
Human researchThymosin alpha-1 is a thymic peptide involved in immune signaling.
Research, risks & sources
Human research- What the name means
- Thymosin alpha-1 is a thymic peptide involved in immune signaling.
- Research & intended effects
- Investigated as an immune-modulating treatment during serious infection. Human sepsis studies examine whether changing immune responses improves outcomes in critically ill patients.
- Possible side effects
- Trials in severely ill patients do not establish a comprehensive safety profile for other uses.
- Interactions
- Drug-interaction data are limited.
Tirzepatide
Clinical referenceTirzepatide activates both GIP and GLP-1 receptors.
Research, risks & sources
Clinical reference- What the name means
- Tirzepatide activates both GIP and GLP-1 receptors.
- Research & intended effects
- Specific medicines are used for diabetes, weight management and obesity-related obstructive sleep apnea.
- Possible side effects
- Common effects include nausea, diarrhea, vomiting, constipation, stomach pain, indigestion or reflux, fatigue, injection-site reactions and hair loss. Dizziness and low blood pressure also occur. Important risks include severe digestive symptoms, dehydration-related kidney injury, pancreatitis, gallbladder problems and serious allergy. The thyroid C-cell tumor warning is based on animal findings; the label excludes people with a personal/family history of medullary thyroid cancer or MEN2.
- Interactions
- Insulin or sulfonylureas increase hypoglycemia risk. Slower stomach emptying can affect oral medicines, including oral hormonal contraception; the label specifies additional contraceptive precautions after starting and each dose increase. Low blood pressure occurs more often with blood-pressure medicines. Delayed stomach emptying also matters during anesthesia or deep sedation.
Vesugen
Early researchVesugen is an experimental short peptide bioregulator.
Research, risks & sources
Early research- What the name means
- Vesugen is an experimental short peptide bioregulator.
- Research & intended effects
- Investigated for blood-vessel maintenance. Laboratory studies examine how endothelial cells—the cells lining vessels—grow and regulate their genes.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
Vilon
Early researchVilon is an experimental short peptide bioregulator.
Research, risks & sources
Early research- What the name means
- Vilon is an experimental short peptide bioregulator.
- Research & intended effects
- Investigated for regulation of cell activity through chromatin, the material that packages DNA. Human-cell experiments explore how short peptides influence the accessibility of genetic information, a proposed starting point for tissue-maintenance research.
- Possible side effects
- Human safety data are limited.
- Interactions
- Drug-interaction data are limited.
VIP
Human researchVIP means vasoactive intestinal peptide, a signaling peptide affecting blood vessels and the digestive tract.
Research, risks & sources
Human research- What the name means
- VIP means vasoactive intestinal peptide, a signaling peptide affecting blood vessels and the digestive tract.
- Research & intended effects
- Aviptadil, a synthetic form, has been investigated in severe respiratory illness.
- Possible side effects
- Diarrhea, flushing and low blood pressure are important possible effects.
- Interactions
- The cited trial does not establish a comprehensive medicine-interaction profile.